Company:  PHARMAGREEN BIOTECH INC. (PHBI)
Form Type:  10-K
Filing Date:  12/30/2019 
CIK:  0001435181 
Address:  2987 BLACKBEAR COURT 
City, State, Zip:  COQUITLAM,  V3E3A2 
Telephone:  702-803-9404 
Fiscal Year:  09/30 
Last Trade
Last Trade: 
$0.10  
Change: 
0.005 (5.56%)  
Trade Time: 
Sep 25  
Market Cap: 
$9.10M
Trade PHBI now with

© 2020  
Description of Business
Pharmagreen Biotech Inc. (the "Company") was incorporated under the laws of the State of Nevada on November 26, 2007. The Company is headquartered in Coquitlam, British Columbia. The Company's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American high CBD hemp, Cannabis and agriculture sectors. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business.
      Item 1A. Risk Factors.
      Item 1B. Unresolved Staff Comments.
      Item 2. Properties.
      Item 3. Legal Proceedings.
      Item 4. Mine Safety Disclosures.
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Capital Resources and Liquidity
        Results of Operations
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to the Consolidated Financial Statements
      Item 9. Changes in and Disagreements With Accountants on ...
      Item 9A. Controls and Procedures.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial Owners and ...
        BENEFICIAL OWNERS
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accounting Fees and Services.
    PART IV
      Item 15. Exhibits, Financial Statement Schedules.
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO